Skip to main content
Maravai LifeSciences Holdings, Inc. (MRVI)
NASDAQ: MRVI · Real-Time Price · USD
3.630
+0.080 (2.25%)
At close: Mar 9, 2026, 4:00 PM EDT
3.610
-0.020 (-0.55%)
After-hours: Mar 9, 2026, 7:37 PM EDT

MRVI Revenue

In the year 2025, Maravai LifeSciences Holdings had annual revenue of $185.74M, down -28.34%. Maravai LifeSciences Holdings had revenue of $49.87M in the quarter ending December 31, 2025, a decrease of -11.83%.

Revenue (ttm)
$185.74M
Revenue Growth
-28.34%
P/S Ratio
5.02
Revenue / Employee
$426,995
Employees
435
Market Cap
933.15M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025185.74M-73.44M-28.34%
Dec 31, 2024259.19M-29.76M-10.30%
Dec 31, 2023288.95M-594.06M-67.28%
Dec 31, 2022883.00M83.76M10.48%
Dec 31, 2021799.24M515.14M181.33%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Fortrea Holdings 2.72B
Xeris Biopharma Holdings 291.85M
Valneva SE 211.09M
UroGen Pharma 109.79M
ARS Pharmaceuticals 84.28M
Arbutus Biopharma 14.61M
Evommune 13.00M
Compass Therapeutics 850.00K
Revenue Rankings

MRVI News

More News